title: Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone.
abstract: Osteopontin (OPN) and bone sialoprotein (BSP) are coexpressed in osteoblasts and osteoclasts, and display overlapping properties. We used daily injection of parathyroid hormone 1-84 (iPTH) over the calvaria of BSP knockout (-/-) mice to investigate further their functional specificity and redundancy. iPTH stimulated bone formation in both +/+ and -/- mice, increasing to the same degree periosteum, osteoid and total bone thickness. Expression of OPN, osterix, osteocalcin (OCN) and DMP1 was also increased by iPTH in both genotypes. In contrast to +/+, calvaria cell cultures from -/- mice revealed few osteoblast colonies, no mineralization and little expression of OCN, MEPE or DMP1. In contrast, OPN levels were 5× higher in -/- versus +/+ cultures. iPTH increased alkaline phosphatase (ALP) activity in cell cultures of both genotypes, with higher OCN and the induction of mineralization in -/- cultures. siRNA blocking of OPN expression did not alter the anabolic action of the hormone in BSP +/+ calvaria, while it blunted iPTH effects in -/- mice, reduced to a modest increase in periosteum thickness. In -/- (not +/+) cell cultures, siOPN blocked the stimulation by iPTH of ALP activity and OCN expression, as well as the induction of mineralization. Thus, full expression of either OPN or BSP is necessary for the anabolic effect of PTH at least in the ectopic calvaria injection model. This suggests that OPN may compensate for the lack of BSP in the response to this hormonal challenge, and provides evidence of functional overlap between these cognate proteins.
authors.affiliation: INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France.
authors.forename: Wafa
authors.initials: W
authors.lastname: Bouleftour
authors.forename: Guenaelle
authors.initials: G
authors.lastname: Bouet
authors.forename: Renata Neves
authors.initials: RN
authors.lastname: Granito
authors.forename: Mireille
authors.initials: M
authors.lastname: Thomas
authors.forename: Marie-Thérèse
authors.initials: MT
authors.lastname: Linossier
authors.forename: Arnaud
authors.initials: A
authors.lastname: Vanden-Bossche
authors.forename: Jane E
authors.initials: JE
authors.lastname: Aubin
authors.forename: Marie-Hélène
authors.initials: MH
authors.lastname: Lafage-Proust
authors.forename: Laurence
authors.initials: L
authors.lastname: Vico
authors.forename: Luc
authors.initials: L
authors.lastname: Malaval
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D058574:Integrin-Binding Sialoprotein / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics*; D051379:Mice; D010012:Osteogenesis / Q000187:drug effects / Q000235:genetics*; D053495:Osteopontin / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics*; D010281:Parathyroid Hormone / Q000008:administration & dosage; D012333:RNA, Messenger / Q000378:metabolism; D012886:Skull / Q000187:drug effects / Q000254:growth & development*
chemical_list: D058574:Integrin-Binding Sialoprotein; D010281:Parathyroid Hormone; D012333:RNA, Messenger; D053495:Osteopontin